| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/11/2000 | US6013798 Water-based composition for decorating substrate, i.e., ceramic or glass with bright gold film upon firing comprising a non-radioactive gold thiolate |
| 01/11/2000 | US6013764 Liquid phase peptide synthesis of KL-4 pulmonary surfactant |
| 01/11/2000 | US6013658 Animal growth regulators |
| 01/11/2000 | US6013647 Benzoxazinedione derivatives, method of producing them and uses thereof |
| 01/11/2000 | US6013632 Administration of one or more of glutathione, its disulfide dimer, ascorbate-2-phosphate, or n-acetyl-l-cysteine, with or without antioxidants |
| 01/11/2000 | US6013462 Purifying or analyzing a human glutathione-s-transferase from a sample by contacting with a solid support coupled to tripeptide analog, and allowing enzyme to adsorb to support |
| 01/11/2000 | US6013458 Conformationally constrained compounds which mimic the secondary structure of biologically active peptides and proteins; for screening libraries |
| 01/11/2000 | US6013263 As inhibitory of human and non-human retroviral, especially human immunodeficiency viurs (hiv), transmission to uninfected cells |
| 01/06/2000 | WO2000000509A2 Peptides for inhibiting hpv e7 proteins |
| 01/06/2000 | WO2000000508A1 Novel aspartyl dipeptide ester derivatives and sweeteners |
| 01/06/2000 | WO2000000470A1 Amino acid derivatives and drugs containing the same as the active ingredient |
| 01/06/2000 | WO2000000464A1 Chiral stationary phases for enantiomers separation and their preparation |
| 01/06/2000 | WO2000000214A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 01/06/2000 | WO1999058505A3 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 01/06/2000 | CA2336162A1 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 01/06/2000 | CA2336133A1 Novel aspartyl dipeptide ester derivatives and sweeteners |
| 01/06/2000 | CA2336105A1 Chiral stationary phases for enantiomers separation and their preparation |
| 01/06/2000 | CA2332127A1 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 01/05/2000 | EP0969015A2 Peptide diagnostic markers for human disorders |
| 01/05/2000 | EP0969013A1 Peptides for inhibiting HPV E7 proteins |
| 01/05/2000 | EP0968227A1 Dimeric cationic lipids on dicystine basis |
| 01/05/2000 | EP0967989A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 01/05/2000 | EP0758342B1 New peptide active substance and production thereof |
| 01/05/2000 | EP0673234B1 Tissue protective and regenerative compositions |
| 01/05/2000 | EP0579661B1 Branched peptides in assays for antibodies |
| 01/05/2000 | EP0570493B1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |
| 01/05/2000 | DE19828113A1 Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV Prodrugs of inhibitors of dipeptidyl peptidase IV |
| 01/04/2000 | US6011175 Inhibition of farnesyltransferase |
| 01/04/2000 | US6011158 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 01/04/2000 | US6011045 Inhibitors of bone resorption; anticancer agents |
| 01/04/2000 | US6011014 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis |
| 01/04/2000 | US6011001 Method of protein therapy by orally administering crosslinked protein crystals |
| 12/29/1999 | WO1999067279A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | WO1999067278A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 12/29/1999 | WO1999066945A1 Compositions and methods for inhibiting bone resorption |
| 12/29/1999 | EP0967223A2 Hepatitis C virus peptide antigens and a method of testing for the hepatitis C virus (HCV) |
| 12/29/1999 | EP0967221A1 Process for preparing pharmacologically acceptable salts of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl amino acids |
| 12/29/1999 | EP0966975A2 Diagnostic agents for pancreatic exocrine function |
| 12/29/1999 | EP0966479A1 Polyprolyl inhibitors of cyclophilin |
| 12/29/1999 | EP0868716A4 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities |
| 12/29/1999 | EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 12/29/1999 | CN1239958A Macrocyclic metal complex carboxylic acids, use and method for production thereof |
| 12/29/1999 | CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion |
| 12/29/1999 | CA2335992A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | CA2335978A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | CA2335471A1 Compositions and methods for inhibiting bone resorption |
| 12/28/1999 | US6008406 Conjugating a semiconjugate of nucleic acid and phenylboronic acid with a phenylboronic acid completeing agent having aromatic ring |
| 12/28/1999 | US6008367 Intermediate for synthesis of anticoagulant agents |
| 12/28/1999 | US6008351 Peptide aldehyde compounds having uracil or pyrimidin-4-one groups as part of the peptide backbone; potent inhibitors of thrombin |
| 12/28/1999 | US6008333 Preparation of glucosaminyl muramic acid derivatives |
| 12/28/1999 | US6008243 An enzyme inhibitor for preventing the degradation and remodeling of connective tissues |
| 12/28/1999 | US6008225 Derivatives of antibiotic GE2270 factors C2a, D2 and E |
| 12/28/1999 | US6008217 An enzyme inhibitor against interleukin-1b, for treating apoptosis-mediated diseases, including inflammatory diseases, autoimmune diseases, proliferative disorders, infectious diseases, and degenerative diseases |
| 12/28/1999 | US6008196 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
| 12/23/1999 | WO1999065932A1 Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors |
| 12/23/1999 | WO1999065922A2 Prenyl transferase inhibitors |
| 12/23/1999 | WO1999065866A1 Anthracene derivatives as anti-cancer agents |
| 12/23/1999 | WO1999065712A2 Glycosulfopeptides and methods of synthesis and use thereof |
| 12/23/1999 | WO1999065299A1 Compositions and methods for expansion of hematopoietic cells |
| 12/23/1999 | WO1999055832A3 Nucleic acid encoding rate agouti related protein |
| 12/23/1999 | CA2337603A1 Prenyl transferase inhibitors |
| 12/23/1999 | CA2334797A1 Anthracene derivatives as anti-cancer agents |
| 12/23/1999 | CA2332563A1 Glycosulfopeptides and methods of synthesis and use thereof |
| 12/22/1999 | EP0964868A1 Isolated peptides derived from mage-2 |
| 12/22/1999 | EP0964867A2 Tachykinin antagonists |
| 12/22/1999 | EP0964690A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 12/22/1999 | CN1047596C Beta-aminoalkyl and beta-N-peptidylaminoalkyl boronic acids |
| 12/21/1999 | US6004952 Micacocidin derivatives |
| 12/21/1999 | US6004934 Tetrapeptide derivative |
| 12/21/1999 | US6004933 Cysteine protease inhibitors |
| 12/21/1999 | US6004906 Plant growth factor |
| 12/21/1999 | US6004768 Crosslinked enzyme or antibody crystals may be used in an assay, diagnostic kit or biosensor for detecting an analyte, in an extracorporeal device for altering a component of a fluid |
| 12/21/1999 | US6004531 Metal chelating compounds having an SNNN donor set |
| 12/16/1999 | WO1999064456A1 A method for preparing a compound with growth hormone releasing properties |
| 12/16/1999 | WO1999064446A1 Pyrazinone protease inhibitors |
| 12/16/1999 | WO1999064445A1 Preparation and purification of a salt of aspartame with acesulfam k |
| 12/16/1999 | WO1999064444A1 Preparation of an organic salt of aspartame with acesulfam h |
| 12/16/1999 | WO1999064443A1 Method for preparing aspartyl cyclohexylalaninamide |
| 12/16/1999 | WO1999064442A1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 12/16/1999 | WO1999064410A1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE |
| 12/16/1999 | WO1999064409A2 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 12/16/1999 | WO1999064050A1 Novel potassium channel drugs and their uses |
| 12/16/1999 | WO1999064043A1 Muscarinic receptor antagonists |
| 12/16/1999 | WO1999064002A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 12/16/1999 | DE19825804A1 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung 1,4-benzothiazepine 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
| 12/16/1999 | CA2334551A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 12/16/1999 | CA2330247A1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 12/16/1999 | CA2318745A1 Novel potassium channel drugs and their uses |
| 12/16/1999 | CA2315883A1 Muscarinic receptor antagonists |
| 12/15/1999 | CN1238780A Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 12/15/1999 | CN1238779A Method and compounds for inhibiting 'beta'-amyloid peptide release and/or synthesis |
| 12/15/1999 | CA2273683A1 Diagnostic markers for human disorders |
| 12/14/1999 | US6001823 Novel pyranosides which are believed to be capable of interacting with periplasmic molecular chaperones |
| 12/14/1999 | US6001814 Serine protease inhibitors |
| 12/14/1999 | US6001813 Val-pro containing α-keto oxadiazoles as serine protease inhibitors |
| 12/14/1999 | US6001811 Serine protease inhibitors--N-substituted derivatives |
| 12/14/1999 | US6001810 Methods for treating retroviral infection |
| 12/14/1999 | US6001809 Peptide having specified amino acid sequence; antiinflammatory agents, in particular for brain disorders |
| 12/14/1999 | CA2014590C Novel peptides, and antidementia agents containing the same |